MIRUS BIO
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina, Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Gr... eece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.
MIRUS BIO
Industry:
Biotechnology Health Care
Founded:
1995-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.mirusbio.com
Total Employee:
11+
Status:
Active
Contact:
6084412849
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Microsoft Exchange Online
Similar Organizations
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Entos Pharmaceuticals
Entos Pharmaceuticals is a healthcare biotechnology company that develops nucleic acid therapies.
Luminetx
Luminetx Corporation discovers, develops, and commercializes bioscience technologies.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Employees Featured
Founder
Official Site Inspections
http://www.mirusbio.com Semrush global rank: 941.31 K Semrush visits lastest month: 37.98 K
- Host name: co-s1.serverpanel.com
- IP address: 216.120.200.151
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mirus Bio"
Mirus Bio - Wikipedia
Mirus Corporation was founded in Madison, Wisconsin in 1995 by three University of Wisconsin - Madison scientists: Jon A. Wolff, James E. Hagstrom and Vladimir G. Budker. Mirus focused on developing innovative non-viral gene delivery technologies for gene therapy applications. These innovations also served as … See moreSee details»
MilliporeSigma Announces Closing of Mirus Bio Acquisition, …
Aug 1, 2024 · Burlington, Massachusetts, August 1, 2024 - MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced that the …See details»
mirus-close | Merck
Aug 1, 2024 · Merck, a leading science and technology company, today announced the closing of the transaction to acquire Mirus Bio for approximately US$ 600 million (around € 550 million), …See details»
MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio ...
May 22, 2024 · BURLINGTON, Mass.-- ( BUSINESS WIRE )--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the …See details»
Mirus Bio - Crunchbase Company Profile & Funding
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. MilliporeSigma acquired Mirus Bio for $600 million to …See details»
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
May 23, 2024 · Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims …See details»
MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio ...
May 22, 2024 · Mirus Bio, part of Gamma Biosciences, is a life science company based in Madison, Wisconsin, USA that specializes in the development and commercialization of …See details»
MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio …
May 24, 2024 · MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced the signing of a definitive agreement to acquire Mirus Bio for …See details»
MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio ...
May 22, 2024 · Burlington, Massachusetts, May 22, 2024 – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the signing of a …See details»
Merck KGaA’s MilliporeSigma to acquire Mirus Bio
Jun 1, 2024 · MilliporeSigma, the North American life sciences business of the German company Merck KGaA, has agreed to acquire Mirus Bio for $600 million. Spun off from the University of …See details»
Definite-Agreement-Mirus-Bio | Merck
May 22, 2024 · Merck, a leading science and technology company, has signed a definitive agreement to acquire life science company Mirus Bio for US$ 600 million (around € 550 …See details»
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to …
May 18, 2021 · Menlo Park, CA and Madison, WI (May 18, 2021) – Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced that it has …See details»
Merck KGaA buys out gene therapy specialist Mirus Bio for $600M
May 23, 2024 · MilliporeSigma, the Massachusetts-based contract manufacturing arm of Merck KGaA, is increasing its presence in the gene therapy manufacturing field as it has signed an …See details»
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to …
May 18, 2021 · Mirus Bio pioneered scientific breakthroughs in non-viral gene delivery and continues to produce industry-leading transfection reagents. As we expand our expertise in …See details»
Mirus Bio Company Profile 2024: Valuation, Investors ... - PitchBook
Provider of gene transfer technologies intended to serve the pharmaceutical industry.See details»
Mirus Bio Receives ISO 13485:2016 Certification
The ISO 13485:2016 standard was developed by the International Organization for Standardization (ISO). Receipt of this certification confirms that Mirus Bio demonstrates the …See details»
Mirus Bio Announces Strategic Investment Partnership with …
Gamma has agreed to make a controlling investment in Mirus Bio. Current Mirus shareholders will retain a substantial equity ownership stake in the company.See details»
Mirus Bio Receives ISO 13485:2016 Certification - PR Newswire
Jan 31, 2024 · Receipt of this certification confirms that Mirus Bio demonstrates the management of its organization meets the framework and principles established by the ISO 13484:2016 …See details»
Kytopen and Mirus Bio Announce Partnership to Unlock New and …
“By combining Mirus Bio’s chemical engineering expertise with Kytopen’s pioneering electro-mechanical gene delivery technology, we will help make the promise of genome engineering a …See details»
Mirus Bio Introduces the VirusGEN® GMP Product Line for Large …
Aug 11, 2021 · Interested parties can visit www.mirusbio.com/GMP for comprehensive information about the VirusGEN GMP Systems and to request a free sample. THE …See details»